Titan Medical Inc (TMDIF)

[QuidWilson]

Right now IP is proportionally high % of our book value but as we commence sales that should shrink, while increasing in nominal value. It's hard to valuate IP in the scope of an R&D firm. Analysts placed us around $23M earlier this year with the offerings if i remeber correctly. Obviously we feel titxf is severely undervalued, and we should see the market correct this as the company gains viability in the market. So as for the value of our IP...who knows right now? Hard to say. It's as good as soccer tickets if we never commercialize. If I were going to guess I would tie it to the present value of perpetual cash flows we realize from their existence, with a discount for all the other inputs into that revenue. Could be a fun exercise for someone with more time than I!